AMINOLEVULINIC ACID HYDROCHLORIDE
| Brand name | LEVULAN |
|---|---|
| Active ingredient | AMINOLEVULINIC ACID HYDROCHLORIDE |
| Strength | 20% |
| Dosage form | SOLUTION |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | December 1999 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11690914 | January 2038 | use U-3163 |
| 11077192 | January 2038 | use U-3163 |
| 12296011 | January 2038 | use U-3163 |
| 10357567 | January 2038 | use U-3163 |
| 11571478 | January 2038 | use U-3163 |
| 11135293 | January 2038 | use U-3163 |
| 11446512 | January 2037 | use U-804 |
| 12290700 | October 2036 | use U-804 |
| 11697028 | October 2036 | use U-804 |
| 11179574 | October 2036 | use U-804 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.